Team Ardelyx had an incredible time attending Equity in GI 2024 hosted by Color of Gastrointestinal Illnesses, Inc. (COGI - Co-Gee) in Atlanta last month! We're committed to promoting equity and inclusion in healthcare and are proud to support COGI in their efforts. #GI
Ardelyx, Inc.
Biotechnology Research
Waltham, MA 14,694 followers
Translating Scientific Breakthroughs into Promise for Patients
About us
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Community Guidelines: https://rb.gy/07ltg3
- Website
-
http://www.ardelyx.com
External link for Ardelyx, Inc.
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Waltham, MA
- Type
- Public Company
- Founded
- 2007
Locations
-
Primary
400 Fifth Avenue
210
Waltham, MA 02451, US
-
34175 Ardenwood Blvd
Fremont, CA 94555, US
-
260 E Highland Ave
Milwaukee, Wisconsin 53202, US
Employees at Ardelyx, Inc.
Updates
-
We’re excited to announce the appointment of Eric Foster to the position of Chief Commercial Officer. Eric is a proven commercial leader with significant experience across global biotech and pharma companies. Welcome to Team Ardelyx! Learn more: https://bit.ly/3WBAH9Y
-
Join Christina J. Hanson, FNP at the 2nd Annual Advanced Practice Provider GI Immersion, where she'll present “Discover a Different Mechanism to Treat Adults with IBS-C: A Case Based Discussion.” Be sure to stop by and learn more with Team Ardelyx. #GI
-
Our team and their families were excited to attend the National Kidney Foundation of Wisconsin's recent Summer Celebration! We're proud to get together with the #kidneydisease community to provide our support and help raise awareness. #ArdelyxProud
-
Team Ardelyx is busy this August attending #GI and #kidneydisease conferences! Check us out at:
-
Today we reported financial results for the second quarter of 2024 and provided a business update. Read the press release here: https://bit.ly/3A9dXXj
-
Thanks to the American Neurogastroenterology and Motility Society for another great conference, see you next year! #ANMS2024
-
Happy #NationalInternDay! We are grateful to have an incredible group of interns with us this summer. They have been learning from and supporting our Sales, Supply Chain, Market Access, Commercial Operations, and Communications teams. #ArdelyxProud
-
#DYK many chronic kidney disease patients on dialysis also struggle with hyperphosphatemia, or high levels of phosphorous in their blood. #kidneydisease #CKD
-
Great work Team Ardelyx! Our team walked over 11,500,00 steps in the International Foundation for Gastrointestinal Disorders (IFFGD)'s Virtual Digestive Health Wellness & Walk Event! We're proud to step up and help raise awareness for the #GI community. #ArdelyxProud